+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

From
From
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • May 2025
  • 88 Pages
  • Global
From
From
From
From
From
From
From
From
From
Female Health Tech Market Report 2024-2034 - Product Thumbnail Image

Female Health Tech Market Report 2024-2034

  • Report
  • April 2024
  • 284 Pages
  • Global
From
Women's Health Market Report 2024-2034 - Product Thumbnail Image

Women's Health Market Report 2024-2034

  • Report
  • March 2024
  • 351 Pages
  • Global
From
From
Monoclonal Antibodies for Oncology: Global Markets - Product Thumbnail Image

Monoclonal Antibodies for Oncology: Global Markets

  • Report
  • June 2022
  • 124 Pages
  • Global
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more